AutoNation, Inc. Common Stock (AN)

Cost of Revenue

$22.55B

TTM · Period ending: · USD

AN logo

AN Cost of Revenue

Latest reported$22.55B
AN TTM Cost of Revenue ($0.00 → $22.55B)
High-resolution chart · PNG

AN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AutoNation, Inc. Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
22,553,100,000
22,553,400,000
22,682,900,000
22,940,100,000
22,544,400,000
22,162,700,000
21,980,000,000
21,560,600,000
21,755,400,000
21,992,900,000
21,817,400,000
21,680,300,000
21,435,400,000
21,388,100,000
21,719,700,000
21,565,300,000
21,319,700,000
21,464,300,000
20,891,400,000
20,432,100,000
19,757,900,000
17,843,800,000
16,826,600,000
16,678,500,000
16,818,900,000
17,533,900,000
17,812,700,000
17,723,200,000
17,643,300,000
17,730,500,000
18,015,500,000
18,268,000,000
18,360,600,000
18,273,600,000
18,175,600,000
18,030,700,000
18,175,300,000
18,321,700,000
18,295,800,000
18,152,000,000
17,944,300,000
17,749,900,000
17,600,500,000
17,337,200,000
16,969,900,000
16,608,300,000
16,120,100,000
15,676,500,000
15,294,600,000
14,981,400,000
14,757,700,000
14,477,700,000
14,014,700,000
13,560,800,000
13,182,400,000
12,740,900,000
12,361,000,000
11,837,400,000
11,528,300,000
11,130,800,000
10,928,000,000
10,753,900,000
10,346,000,000
9,982,000,000
9,654,200,000
9,208,500,000
8,874,000,000
8,781,800,000
9,332,600,000
10,461,600,000
11,789,300,000
13,076,700,000
14,000,200,000
14,571,700,000
14,903,700,000
15,088,700,000
15,392,700,000
15,769,200,000
16,009,400,000
16,028,200,000
16,238,200,000
16,281,200,000
16,242,100,000
16,447,500,000
16,387,600,000
16,353,300,000
16,360,700,000
16,321,300,000
16,460,100,000
16,537,800,000
16,418,300,000
16,284,000,000
16,245,700,000
16,214,200,000
16,492,000,000
17,250,800,000
17,073,400,000
16,995,200,000
17,115,400,000
16,571,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.